Anna Filipowicz-Sosnowska Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2007	[The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis].
7/2002	High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Filipowicz-Sosnowska Research Topics

Disease

8	Rheumatoid Arthritis 01/2017 - 07/2002
2	Persistent Infection 01/2009 - 05/2006
2	Arthritis (Polyarthritis) 06/2007 - 01/2005
2	Infections 05/2006 - 06/2004
1	Inflammation (Inflammations) 01/2017
1	Thyroid Diseases (Thyroid Disease) 01/2009
1	Proteinuria 06/2007
1	Familial Mediterranean Fever (Periodic Disease) 06/2007
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2007
1	Neurologic Manifestations (Neurological Manifestations) 01/2007
1	Atherosclerosis 01/2007
1	Disease Progression 05/2006
1	Urinary Tract Infections (Urinary Tract Infection) 05/2006
1	Vasculitis (Vasculitides) 05/2006
1	Spondylarthropathies 01/2005

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 01/2009 - 01/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2009 - 05/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2007 - 07/2002
2	Anticardiolipin AntibodiesIBA 01/2007 - 05/2006
2	Antiphospholipid AntibodiesIBA 01/2007 - 05/2006
2	Rituximab (Mabthera)FDA Link 05/2006 - 06/2004
2	Methotrexate (Mexate)FDA LinkGeneric 05/2006 - 06/2004
1	Pharmaceutical PreparationsIBA 01/2017
1	CreatinineIBA 06/2007
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2007
1	Rheumatoid FactorIBA 01/2007
1	Antirheumatic Agents (DMARD)IBA 05/2006
1	Biological ProductsIBA 05/2006
1	GlucocorticoidsIBA 05/2006
1	Indicators and Reagents (Reagents)IBA 05/2006
1	enterobacterial common antigenIBA 01/2005
1	DNA (Deoxyribonucleic Acid)IBA 01/2005
1	Bacterial DNAIBA 01/2005
1	LipopolysaccharidesIBA 01/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2004
1	RANK LigandIBA 07/2002
1	OsteoprotegerinIBA 07/2002
1	CytokinesIBA 07/2002

Therapy/Procedure

3	Therapeutics 05/2006 - 07/2002